Pashupati Cotspin Ltd (PASHUPATI) Share Price & Fundamentals

What we do

Pashupati Cotspin Ltd processes raw cotton into cotton bales, yarn, and cotton seeds, serving the textile industry with ginning and spinning operations.

Founded in

2,013

Market share

A growing player in cotton ginning and spinning with a robust regional presence near cotton-growing areas.

Problem solved

Facilitates cotton processing integration addressing fashion trends, textile sector growth, and government initiatives.

Top clients or who we serve

Textile manufacturers and related industries; primarily B2B segment.

Key management

Managing Director: Mr. Saurin Jagdish Bhai Parikh; Whole-time Director: Mr. Tushar Rameshchandra Trivedi; CFO: Mr. Hareshkumar Rameshchandra Shah.

Our journey and innovations

Founded in 2013, converted to public limited in 2017, IPO in 2017, diversified into pharmaceuticals in 2023.

Where we operate

Manufacturing in Gujarat, serving Indian textile markets with growth potential in pharmaceuticals.

Top products or what we offer

Cotton bales, cotton yarn, black cotton seeds; diversified into pharmaceuticals recently.

Top brands

Not specified by brand names; core products include cotton yarn and ginned cotton.

Raw materials needed

Raw cotton sourced from Maharashtra and Gujarat cotton-growing regions.

Raw materials supplier

Primarily local cotton growers in Maharashtra and Saurashtra region of Gujarat.

Recurring vs cyclical contribution

Revenue driven mainly from cyclical cotton harvesting seasons, with stable order flow due to integration.

Our industry position

Emerging regional player with forward integration in cotton textile processing sectors.

Financial highlights

FY 2024-25 revenue approximately Rs. 650.67 crore, Net Profit Rs. 12.88 crore, steady growth in profitability.

Geographical revenue split

Revenue primarily from Indian markets, centered around Gujarat and Maharashtra.

Order book

-

Whats driving growth

Expansion of spinning capacity, diversification into pharmaceuticals, strategic location near cotton zones.

Our future plans

Further scaling manufacturing and pharmaceutical diversification, capitalizing on main board listing benefits.

Our green promise

-

Our people and values

Dedicated workforce focused on innovation, quality, and compliance with strong governance culture.

Key challenges ahead

Volatility in raw cotton prices, market competition, and managing new sector diversification risks.

Interesting facts

Successfully migrated to main stock exchange board in 2025; diversified into pharmaceuticals in 2023.

Risks and strategy

Mitigates raw material price volatility through proximity sourcing; cautious expansion into pharmaceuticals.